These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1280444)

  • 21. Oligonucleotide technologies: synthesis, production, regulations and applications. 29-30th November 2000, Hamburg, Germany.
    Uhlmann E
    Expert Opin Biol Ther; 2001 Mar; 1(2):319-28. PubMed ID: 11727539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical potential of oligonucleotide-based therapeutics in the respiratory system.
    Moschos SA; Usher L; Lindsay MA
    Pharmacol Ther; 2017 Jan; 169():83-103. PubMed ID: 27771436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unlocked nucleic acid--an RNA modification with broad potential.
    Pasternak A; Wengel J
    Org Biomol Chem; 2011 May; 9(10):3591-7. PubMed ID: 21431171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of mRNA translation by complementary oligonucleotides covalently linked to intercalating agents.
    Toulmé JJ; Krisch HM; Loreau N; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1227-31. PubMed ID: 3513172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making antisense of splicing.
    Garcia-Blanco MA
    Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EvOligo: A Novel Software to Design and Group Libraries of Oligonucleotides Applicable for Nucleic Acid-Based Experiments.
    Milewski MC; Kamel K; Kurzynska-Kokorniak A; Chmielewski MK; Figlerowicz M
    J Comput Biol; 2017 Oct; 24(10):1014-1028. PubMed ID: 28294640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Medicinal Chemistry of Therapeutic Oligonucleotides.
    Wan WB; Seth PP
    J Med Chem; 2016 Nov; 59(21):9645-9667. PubMed ID: 27434100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence-specific purification of nucleic acids by PNA-controlled hybrid selection.
    Orum H; Nielsen PE; Jørgensen M; Larsson C; Stanley C; Koch T
    Biotechniques; 1995 Sep; 19(3):472-80. PubMed ID: 7495562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of 2'-O-Me RNA/ENA chimera oligonucleotides to induce exon skipping in dystrophin pre-mRNA.
    Takagi M; Yagi M; Ishibashi K; Takeshima Y; Surono A; Matsuo M; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):297-8. PubMed ID: 17150596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic oligonucleotides with polyethylene glycol modifications.
    Winkler J
    Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of DNA hairpin loops and a complementary strand by a triplet of base pairs.
    Baumann U; Frank R; Blöcker H
    Biochem Biophys Res Commun; 1988 Dec; 157(3):986-91. PubMed ID: 3207430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ hybridization histochemistry with synthetic oligonucleotides: strategies and methods.
    Lewis ME; Sherman TG; Watson SJ
    Peptides; 1985; 6 Suppl 2():75-87. PubMed ID: 4080619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ECHO-LNA conjugates: hybridization-sensitive fluorescence and its application to fluorescent detection of various RNA strands.
    Sugizaki K; Okamoto A
    Bioconjug Chem; 2010 Dec; 21(12):2276-81. PubMed ID: 21090641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reactive oligonucleotide derivatives as potential antiviral preparations].
    Knorre DG; Vlasov VV
    Vopr Virusol; 1985; 30(5):524-9. PubMed ID: 2416132
    [No Abstract]   [Full Text] [Related]  

  • 36. Applications of oligonucleotide synthesis to interferon research.
    Edge MD; Markham AF
    Biochim Biophys Acta; 1982 Sep; 695(1):35-48. PubMed ID: 6182910
    [No Abstract]   [Full Text] [Related]  

  • 37. Towards Improved Oligonucleotide Therapeutics Through Faster Target Binding Kinetics.
    Menzi M; Wild B; Pradère U; Malinowska AL; Brunschweiger A; Lightfoot HL; Hall J
    Chemistry; 2017 Oct; 23(57):14221-14230. PubMed ID: 28746731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of pre-mRNA splicing by antisense oligonucleotides.
    Kole R
    Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleic acids delivering nucleic acids.
    Catuogno S; Esposito CL; Condorelli G; de Franciscis V
    Adv Drug Deliv Rev; 2018 Sep; 134():79-93. PubMed ID: 29630917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotides made of 2'-O-alkylRNA: their properties and applications in RNA biochemistry.
    Lamond AI; Sproat BS
    FEBS Lett; 1993 Jun; 325(1-2):123-7. PubMed ID: 7685712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.